MCMedicalCodingSoftware
J1457

J1457: Injection, gallium nitrate, 1 mg

HCPCSTerminatedBETOS O1E

J1457 is a HCPCS Level II code for injection, gallium nitrate, 1 mg. It belongs to the Drugs Administered Other Than Oral Method section. It was terminated on December 31, 2025 and is not valid on new claims.

This code has been terminated

CMS terminated J1457 on December 31, 2025. It stays in the file as history: a claim you are auditing from before that date may legitimately carry it, but it must not appear on a new claim. The adjacent codes below are the usual place to look for its replacement.

Medicare coverage: Carrier judgment

Coverage is decided by your Medicare contractor, not by national policy. Whether this is paid depends on the LCD for your jurisdiction and on what the documentation supports.

From the coverage field of the CMS Alpha-Numeric HCPCS File, release 2026Q4-Oct. This states Medicare’s position on the code, not on your particular claim.

The CMS record for J1457

Long descriptor
Injection, gallium nitrate, 1 mg

The official wording. This is what the code means.

Short descriptor
Gallium nitrate injection

CMS's 28-character form, which is what shows up on a remittance advice.

Added
January 1, 2005

When CMS introduced the code.

Terminated
December 31, 2025

When CMS retired it.

BETOS
O1E

Berenson-Eggers Type of Service: CMS's own analytic grouping.

Pricing indicator
51: Other

Drugs.

Codes adjacent to J1457

HCPCS has no hierarchy: related items simply sit next to each other in the numbering. If J1457 is not quite right, the correct code is very often within a few positions of it.

  • J1449Injection, eflapegrastim-xnst, 0.1 mg
  • J1450Injection fluconazole, 200 mg
  • J1451Injection, fomepizole, 15 mg
  • J1452Injection, fomivirsen sodium, intraocular, 1.65 mgterminated
  • J1453Injection, fosaprepitant, 1 mg
  • J1454Injection, fosnetupitant 235 mg and palonosetron 0.25 mg
  • J1455Injection, foscarnet sodium, per 1000 mg
  • J1456Injection, fosaprepitant (teva), not therapeutically equivalent to j1453, 1 mg
  • J1458Injection, galsulfase, 1 mg
  • J1459Injection, immune globulin (privigen), intravenous, non-lyophilized (e.g., liquid), 500 mg
  • J1460Injection, gamma globulin, intramuscular, 1 cc
  • J1551Injection, immune globulin (cutaquig), 100 mg
  • J1552Injection, immune globulin (alyglo), 500 mg
  • J1553Injection, immune globulin (yimmugo), 100 mg
  • J1554Injection, immune globulin (asceniv), 500 mg
  • J1555Injection, immune globulin (cuvitru), 100 mg
HCPCS Level II2026Q4-Oct· effective October 1, 2026